Disease landscape analysis provides a deeper understanding of unmet needs, treatment evolution, and emerging opportunities. Integrated with healthcare ecosystem mapping and pharmaceutical competitive intelligence, it enables organizations to strengthen portfolio decisions and identify high-value markets. Discover how intelligence-driven analysis supports informed healthcare strategy.